Shares of Shionogi & Co., Ltd. (OTCMKTS:SGIOF – Get Free Report) were down 6.7% during mid-day trading on Monday . The company traded as low as $17.65 and last traded at $17.65. 100 shares were traded during trading, a decline of 95% from the average session volume of 1,910 shares. The stock had previously closed at $18.9080.
Shionogi & Co., Ltd. Stock Down 6.7%
The company has a 50 day simple moving average of $18.02 and a 200-day simple moving average of $19.40.
About Shionogi & Co., Ltd.
Shionogi & Co, Ltd. is a research-driven pharmaceutical company headquartered in Osaka, Japan, with origins dating back to 1878. The company concentrates on the discovery, development and sale of prescription medicines in key therapeutic areas, including infectious diseases, pain management, cardiovascular and metabolic disorders, central nervous system disorders and oncology. Shionogi’s mission emphasizes addressing unmet medical needs, particularly in the field of antimicrobial resistance, where it has developed both small-molecule antibiotics and novel treatment approaches.
The firm’s product portfolio comprises marketed therapies such as Cresemba (isavuconazole) for invasive fungal infections, and Fetroja (cefiderocol), a siderophore cephalosporin antibiotic for multidrug-resistant Gram-negative infections.
See Also
- Five stocks we like better than Shionogi & Co., Ltd.
- Securing AI: 5 Most-Upgraded Stocks From the Q2 Reporting Season
- Insiders Are Betting Big on These 3 Healthcare Stocks
- 3 Stocks for Investors Who Still Believe Cash Is King
- Dollar General and Dollar Tree Are Recovering, But Not for the Same Reason
Receive News & Ratings for Shionogi & Co. Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Shionogi & Co. Ltd. and related companies with MarketBeat.com's FREE daily email newsletter.
